Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 817 to 818 of 818 entries
Sorted by: Best Match Show Resources per page
Reducing non-melanoma skin cancer risk in renal transplant recipients.

Nephrology (Carlton, Vic.)

Thet Z, Lam AK, Ranganathan D, Aung SY, Han T, Khoo TK.
PMID: 34240786
Nephrology (Carlton). 2021 Nov;26(11):907-919. doi: 10.1111/nep.13939. Epub 2021 Jul 28.

With an increasing number of renal transplant recipients (RTRs) and improving patient survival, a higher incidence of non-melanoma skin cancer (NMSC) has been observed. NMSC in RTRs are often more numerous and biologically more aggressive than the general population,...

Cite
Thet Z, Lam AK, Ranganathan D, et al. Reducing non-melanoma skin cancer risk in renal transplant recipients. Nephrology (Carlton). 2021;26(11):907-919doi: 10.1111/nep.13939.
Thet, Z., Lam, A. K., Ranganathan, D., Aung, S. Y., Han, T., & Khoo, T. K. (2021). Reducing non-melanoma skin cancer risk in renal transplant recipients. Nephrology (Carlton, Vic.), 26(11), 907-919. https://doi.org/10.1111/nep.13939
Thet, Zaw, et al. "Reducing non-melanoma skin cancer risk in renal transplant recipients." Nephrology (Carlton, Vic.) vol. 26,11 (2021): 907-919. doi: https://doi.org/10.1111/nep.13939
Thet Z, Lam AK, Ranganathan D, Aung SY, Han T, Khoo TK. Reducing non-melanoma skin cancer risk in renal transplant recipients. Nephrology (Carlton). 2021 Nov;26(11):907-919. doi: 10.1111/nep.13939. Epub 2021 Jul 28. PMID: 34240786.
Copy Download .nbib Format: NLM
Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer.

Cancers

Safi SA, Haeberle L, Rehders A, Fung S, Vaghiri S, Roderburg C, Luedde T, Ziayee F, Esposito I, Fluegen G, Knoefel WT.
PMID: 35008232
Cancers (Basel). 2021 Dec 23;14(1). doi: 10.3390/cancers14010068.

BACKGROUND: Survival following surgical treatment of ductal adenocarcinoma of the pancreas (PDAC) remains poor. The recent implementation of the circumferential resection margin (CRM) into standard histopathological evaluation lead to a significant reduction in R0 rates. Mesopancreatic fat infiltration is...

Cite
Safi SA, Haeberle L, Rehders A, et al. Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010068.
Safi, S. A., Haeberle, L., Rehders, A., Fung, S., Vaghiri, S., Roderburg, C., Luedde, T., Ziayee, F., Esposito, I., Fluegen, G., & Knoefel, W. T. (2021). Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer. Cancers, 14(1), . https://doi.org/10.3390/cancers14010068
Safi, Sami-Alexander, et al. "Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010068
Safi SA, Haeberle L, Rehders A, Fung S, Vaghiri S, Roderburg C, Luedde T, Ziayee F, Esposito I, Fluegen G, Knoefel WT. Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer. Cancers (Basel). 2021 Dec 23;14(1). doi: 10.3390/cancers14010068. PMID: 35008232.
Copy Download .nbib Format: NLM
Showing 817 to 818 of 818 entries